All Stories

  1. Health‐Related Quality of Life Among Patients With Ostomy Intestinal Stoma According to Sex and Ostomy Permanence: A Systematic Review and Meta‐Analysis
  2. Infusion-Related Reactions Among Cancer Patients Receiving Immune Checkpoint Inhibitors: The ARON-MOUSEION-013 Systematic Review and Meta-Analysis
  3. Association Between Mediterranean Diet Consumption and the Physical and Mental Components of HRQL in Community-Dwelling Older Adults in Valencia
  4. Abstracts from the 1st International Online Conference on Diseases
  5. Association Between Sleep Disturbance and Behavioral Feeding Problems in Children and Adolescents with Autism Spectrum Disorder
  6. Fallskip® Parameters and Their Relationship with the Risk of Falls in Older Individuals with and Without Diabetes
  7. Analysis of the Association Between Symptoms of Inattention and Hyperactivity–Impulsivity and Substance Abuse in University Students
  8. The Associations Between Chronotype and Mental Health in Nursing Students
  9. Salivary 1,5-Anhydroglucitol and AGEs Are Associated with Postural Instability in Diabetic Foot Patients
  10. Normal Weight, Overweight and Obesity Conditions Associated to Prostate Neoplasm Stages—A Systematic Review and Meta-Analysis
  11. Treatment-Related Adverse Events in Extended Stage Small Cell Lung Cancer Patients Receiving First-Line Chemoimmunotherapy Versus Chemotherapy Alone: A Systematic Review and Meta-Analysis
  12. Plasma IL-1β Concentration Associates with Sleep Quality and Cognitive Functions in Men with Prostate Cancer
  13. Non-Pharmacological Interventions for Managing the Symptoms of Depression in Women with Breast Cancer: A Literature Review of Clinical Trials
  14. Effects of a Multimodal Program on Frailty Syndrome and Psychological Alterations in Breast Cancer Women Treated with Aromatase Inhibitors
  15. Obesity and Adipose-Derived Extracellular Vesicles: Implications for Metabolic Regulation and Disease
  16. The Long-Lasting Effect of Multidisciplinary Interventions for Emotional and Social Loneliness in Older Community-Dwelling Individuals: A Systematic Review
  17. Social and Mental Health Factors Involved in the Severity of Loneliness in Older Individuals in a Spanish Rural Area
  18. Impact of a Physical Exercise and Health Education Program on Metabolic Syndrome and Quality of Life in Postmenopausal Breast Cancer Women Undergoing Adjuvant Treatment with Aromatase Inhibitors
  19. Long-Term Caregiving Impact and Self-Care Strategies in Family Caregivers of People with Neuropsychiatric Disorders: A Mixed-Method Study
  20. Salivary IL-1 Beta Level Associated with Poor Sleep Quality in Children/Adolescents with Autism Spectrum Disorder
  21. Effect of a Physical Exercise Intervention on Physical Function Parameters and Blood Analytical Changes in Lung Cancer Survivors: A Feasibility Study
  22. Association between Hand Hygiene Knowledge and Self-Efficacy in Nursing Students: A Multicenter Cross-Sectional Study within the Framework of the Erasmus Project
  23. Autistic Children/Adolescents Have Lower Adherence to the Mediterranean Diet and Higher Salivary IL-6 Concentration: Potential Diet–Inflammation Links?
  24. Factors Affecting Sleep Quality among University Medical and Nursing Students: A Study in Two Countries in the Mediterranean Region
  25. The Association between Functional Health Patterns and Frailty in Hospitalized Geriatric Patients
  26. Salivary Brain-Derived Neurotrophic Factor and Cortisol Associated with Psychological Alterations in University Students
  27. Inflammatory Biomarkers and Gait Impairment in Older Adults: A Systematic Review
  28. Psychological Alterations in Youths with Type I Diabetes: Associations with Salivary Cortisol Concentration
  29. Plasma Androstenedione Concentration Can Discriminate Frail versus Non-Frail Men with Prostate Cancer under Androgen Deprivation Therapy
  30. Wearable sensors-based postural analysis and fall risk assessment among patients with diabetic foot neuropathy
  31. Can Leucine Supplementation Improve Frailty Index Scores?
  32. Increased Salivary IL-1 Beta Level Is Associated with Poor Sleep Quality in University Students
  33. Evaluating video virtual reality teaching for nursing students
  34. Relationship between Cognitive Impairment and Depressive Symptoms with Somatosensory Functions in Diabetic and Non-Diabetic Older Adults and Its Impact on Quality of Life
  35. Association between Depressive Symptoms and Adherence to the Mediterranean Diet in Nursing Students
  36. Actigraphy Analysis of Sleep Associates with Salivary IL-6 Concentration in Institutionalized Older Individuals
  37. Editorial: Food-polyphenol-induced modulation of neurodegeneration
  38. Salivary Interleukin 1-Beta Concentration Associates With Sleep Quality in Older Individuals
  39. Comparison of Frailty Criteria, Cognitive Function, Depressive and Insomnia Symptoms in Men with Localized and Advanced Prostate Cancer under Androgen Deprivation Therapy
  40. Relationship between deep and superficial sensitivity assessments and gait analysis in diabetic foot patients
  41. Analysis of Frailty Syndrome in Men with Metastatic Prostate Cancer: A Scoping Review
  42. Social and Emotional Loneliness in Older Community Dwelling-Individuals: The Role of Socio-Demographics
  43. The Effects of 3D Custom Foot Orthotics with Mechanical Plantar Stimulation in Older Individuals with Cognitive Impairment: A Pilot Study
  44. Mediterranean Diet Adherence in Community-Dwelling Older Adults in Spain: Social Determinants Related to the Family
  45. Perceived mental health and emotional trajectories of long-term family caregivers of persons with mental conditions: A mixed-methods study
  46. Adjuvant aromatase inhibitor treatment worsens depressive symptoms and sleep quality in postmenopausal women with localized breast cancer: A one-year follow-up study
  47. The Effects of Probiotics and Prebiotics on Gastrointestinal and Behavioural Symptoms in Autism Spectrum Disorder
  48. Respiratory Function Correlates with Fat Mass Index and Blood Triglycerides in Institutionalized Older Individuals
  49. Salivary Biomarkers Associated with Psychological Alterations in Patients with Diabetes: A Systematic Review
  50. Androstenedione and Follicle-Stimulating Hormone Concentration Predict the Progression of Frailty Syndrome at One Year Follow-Up in Patients with Localized Breast Cancer Treated with Aromatase Inhibitors
  51. Plasma Nickel Levels Correlate with Low Muscular Strength and Renal Function Parameters in Patients with Prostate Cancer
  52. Foot Orthosis and Sensorized House Slipper by 3D Printing
  53. Effectiveness of cognitive behavioral therapy-based interventions on psychological symptoms in adults with type 2 diabetes mellitus: An update review of randomized controlled trials
  54. Knowledge and Attitudes towards Palliative Care: Validation of the Spanish Version of Questionnaire on Palliative Care for Advanced Dementia
  55. Plasma Aromatase Activity Index, Gonadotropins and Estrone Are Associated with Frailty Syndrome in Post-Menopausal Women with Breast Cancer
  56. Salivary IL-6 Concentration Is Associated with Frailty Syndrome in Older Individuals
  57. Personal and Social Consequences of Psychotropic Substance Use: A Population-Based Internet Survey
  58. Prenatal exposure to phthalates and its effects upon cognitive and motor functions: A systematic review
  59. Wearable Sensor for Assessing Gait and Postural Alterations in Patients with Diabetes: A Scoping Review
  60. Circadian Rhythm and Concentration of Melatonin in Breast Cancer Patients
  61. Cognitive Functions under Anti-HER2 Targeted Therapy in Cancer Patients: A Scoping Review
  62. Chemotherapy-Induced Neuropathy and Diabetes: A Scoping Review
  63. Lymphocytes as a Biomarker of Frailty Syndrome: A Scoping Review
  64. Oxidative Stress and Cognitive Alterations Induced by Cancer Chemotherapy Drugs: A Scoping Review
  65. Differences and Similarities in Neuropathy in Type 1 and 2 Diabetes: A Systematic Review
  66. Analysis of Brain Functions in Men with Prostate Cancer under Androgen Deprivation Therapy: A One-Year Longitudinal Study
  67. Special Issue “Mental Health Issues and Quality of Life in Older Individuals”
  68. Changes in Salivary Amylase and Glucose in Diabetes: A Scoping Review
  69. Salivary Inflammatory Molecules as Biomarkers of Sleep Alterations: A Scoping Review
  70. Weight Loss and Improvement of Metabolic Alterations in Overweight and Obese Children Through the I2AO2 Family Program: A Randomized Controlled Clinical Trial
  71. Hair Cortisol Concentration as a Biomarker of Sleep Quality and Related Disorders
  72. Effects of Probiotics in the Management of Infected Chronic Wounds: From Cell Culture to Human Studies
  73. New Effects of Prebiotics, Probiotics, and Symbiotics
  74. The Association between Cognitive Impairment and Diabetic Foot Care: Role of Neuropathy and Glycated Hemoglobin
  75. Salivary Stress/Immunological Markers in Crohn’s Disease and Ulcerative Colitis
  76. Omega-3 Long-Chain Polyunsaturated Fatty Acids Intake in Children: The Role of Family-Related Social Determinants
  77. Immune Alterations in Frailty Syndrome and Cognitive Impairment
  78. Quality of Life in Individuals with Diabetic Foot Syndrome
  79. The Association between Peripheral Blood Cells and the Frailty Syndrome in Patients with Cardiovascular Diseases
  80. Neurotransmitters and Behavioral Alterations Induced by Nickel Exposure
  81. Kaempferol as a Dietary Anti-Inflammatory Agent: Current Therapeutic Standing
  82. Respiratory Muscle Strengths and Their Association with Lean Mass and Handgrip Strengths in Older Institutionalized Individuals
  83. Therapeutic potential of alkaloids in autoimmune diseases: Promising candidates for clinical trials
  84. Interleukin-6 and Lymphocyte Count Associated and Predicted the Progression of Frailty Syndrome in Prostate Cancer Patients Undergoing Antiandrogen Therapy
  85. Mechanical Plantar Foot Stimulation in Parkinson′s Disease: A Scoping Review
  86. Effects of Leucine Administration in Sarcopenia: A Randomized and Placebo-controlled Clinical Trial
  87. Resveratrol in Autism Spectrum Disorders: Behavioral and Molecular Effects
  88. Therapeutic Plasmapheresis with Albumin Replacement in Alzheimer’s Disease and Chronic Progressive Multiple Sclerosis: A Review
  89. Beneficial Effect of Foot Plantar Stimulation in Gait Parameters in Individuals with Parkinson’s Disease
  90. Peripheral Oxidative Stress Markers in Patients with Bipolar Disorder during Euthymia and in Siblings
  91. Sleep quality and its association with substance abuse among university students
  92. Neuro-Psychiatric Alterations in Patients with Diabetic Foot Syndrome
  93. Alcohol and Drug Use in European University Health Science Students: Relationship with Self-Care Ability
  94. Frailty syndrome is associated with changes in peripheral inflammatory markers in prostate cancer patients undergoing androgen deprivation therapy
  95. Sleep assessment devices: types, market analysis, and a critical view on accuracy and validation
  96. Effects of l-Carnitine in Patients with Autism Spectrum Disorders: Review of Clinical Studies
  97. Decrease in Serum Vitamin D Level of Older Patients with Fatigue
  98. Beneficial Effects of Leucine Supplementation on Criteria for Sarcopenia: A Systematic Review
  99. Analysis of Functional and Cognitive Impairment in Institutionalized Individuals with Movement Disorders
  100. Alcohol and Cannabis Intake in Nursing Students
  101. Neuro-Psychiatric Disorders: From Diagnosis to Care
  102. First Case Report of Primary Carnitine Deficiency Manifested as Intellectual Disability and Autism Spectrum Disorder
  103. Delay in the Diagnosis of Breast and Colorectal Cancer in People With Severe Mental Disorders
  104. Omega-3 Long-Chain Polyunsaturated Fatty Acids Intake in Children with Attention Deficit and Hyperactivity Disorder
  105. Relationship between mobility and cognitive impairment in patients with Alzheimer’s disease
  106. Skeletal alterations, developmental delay and new mutations in juvenile-onset Pompe disease
  107. Quality of Life in People with Coeliac Disease: Psychological and Socio- Economic Aspects
  108. Subjective neurocognition and quality of life in patients with bipolar disorder and siblings
  109. Can a Prebiotic Formulation Reduce Frailty Levels in Older People?
  110. Changes in Chemokines and Chemokine Receptors Expression in a Mouse Model of Alzheimer's Disease
  111. Staging, Neurocognition and Social Functioning in Bipolar Disorder
  112. Cognitive impairment associated with chronic lead exposure in adults
  113. Interventions aimed to increase independence and well-being in patients with Alzheimer’s disease: Review of some interventions in the Italian context
  114. Quality of life related to clinical features in patients with Rett syndrome and their parents: a systematic review
  115. Blood zinc levels and cognitive and functional evaluation in non-demented older patients
  116. Homocysteine Levels in Autism Spectrum Disorder: A Clinical Update
  117. Changes in the Peripheral Endocannabinoid System as a Risk Factor for the Development of Eating Disorders
  118. Editorial: Metabolic and Hormonal Alterations in Neuro-Psychiatric Disorders
  119. A survey on sleep assessment methods
  120. Venlafaxine prevents morphine antinociceptive tolerance: The role of neuroinflammation and the l -arginine-nitric oxide pathway
  121. Subjective and objective sleep quality in elderly individuals: The role of psychogeriatric evaluation
  122. Frailty and leucocyte count are predictors of all-cause mortality and hospitalization length in non-demented institutionalized older women
  123. A survey on sleep questionnaires and diaries
  124. Febrile seizure and related syndromes
  125. The Effect of Moderate- Versus High-Intensity Resistance Training on Systemic Redox State and DNA Damage in Healthy Older Women
  126. Non-pharmacological interventions in patients with spinal cord compression: a systematic review
  127. Blood Infusion and the Risk of Haemorrhage in Patients Undergoing Cardiac Surgery with Extracorporeal Circulation
  128. Clinical staging and serum cytokines in bipolar patients during euthymia
  129. The effect of probiotics as a treatment for constipation in elderly people: A systematic review
  130. Research in Medical–Surgical Nursing
  131. Sleep Alterations in Non-demented Older Individuals: The Role of Cortisol
  132. Relationship between adipic acid concentration and the core symptoms of autism spectrum disorders
  133. Effect of a Prebiotic Formulation on Frailty Syndrome: A Randomized, Double-Blind Clinical Trial
  134. Serum vitamin D and functional impairment in octogenarian women
  135. Brain-derived neurotrophic factor correlates with functional and cognitive impairment in non-disabled older individuals
  136. Usefulness of Clinical Data and Biomarkers for the Identification of Frailty After Acute Coronary Syndromes
  137. Frailty syndrome and pre-operative risk evaluation: A systematic review
  138. Increased homocysteine levels correlate with the communication deficit in children with autism spectrum disorder
  139. Non-chemotherapy drug-induced agranulocytosis in a tertiary hospital
  140. Lead Excretion in Spanish Children with Autism Spectrum Disorder
  141. Autism and Intellectual Disability Associated with Mitochondrial Disease and Hyperlactacidemia
  142. The relationship between depression and frailty syndrome: a systematic review
  143. Multiparametric magnetic resonance in the assessment of the gender differences in a high-grade glioma rat model
  144. Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degeneration?
  145. Clinical features of prefrail older individuals and emerging peripheral biomarkers: A systematic review
  146. The value of neutrophil and lymphocyte count in frail older women
  147. Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in vitro: implications for treatment of ovarian hyperstimulation syndrome with dopamine receptor 2 agonists
  148. Interleukin 6 and cognitive dysfunction
  149. Non invasive blood flow measurement in cerebellum detects minimal hepatic encephalopathy earlier than psychometric tests
  150. Blocking NMDA Receptors Delays Death in Rats with Acute Liver Failure by Dual Protective Mechanisms in Kidney and Brain
  151. Pregnenolone Sulfate Restores the Glutamate-Nitric-Oxide-cGMP Pathway and Extracellular GABA in Cerebellum and Learning and Motor Coordination in Hyperammonemic Rats
  152. Gender differences in Neurotoxicity
  153. Gender differential effects of developmental exposure to methyl-mercury, polychlorinated biphenyls 126 or 153, or its combinations on motor activity and coordination
  154. Cerebral oedema is not responsible for motor or cognitive deficits in rats with hepatic encephalopathy
  155. Autism spectrum disorders associated to a deficiency of the enzymes of the mitochondrial respiratory chain
  156. Hyperammonemia alters the modulation by different neurosteroids of the glutamate–nitric oxide–cyclic GMP pathway through NMDA‐ GABAA‐ or sigma receptors in cerebellumin vivo
  157. Behavioral deficits induced by lead exposure are accompanied by serotonergic and cholinergic alterations in the prefrontal cortex
  158. Chronic hyperammonemia, glutamatergic neurotransmission and neurological alterations
  159. Sildenafil citrate improves perinatal outcome in fetuses from pre‐eclamptic rats
  160. Alteration of serotonin system by polychlorinated biphenyls exposure
  161. Gender-dependent behavioural impairment and brain metabolites in young adult rats after short term exposure to lead acetate
  162. An Inhibitor of Neuronal Exocytosis (DD04107) Displays Long-Lasting In Vivo Activity against Chronic Inflammatory and Neuropathic Pain
  163. Exploratory investigation on nitro- and phospho-proteome cerebellum changes in hyperammonemia and hepatic encephalopathy rat models
  164. Differential modulation of the glutamate-nitric oxide-cyclic GMP pathway by distinct neurosteroids in cerebellum in vivo
  165. p38 MAP kinase is a therapeutic target for hepatic encephalopathy in rats with portacaval shunts
  166. 3-Nitro-Tyrosine as a Peripheral Biomarker of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis
  167. Alterations of apparent diffusion coefficient (ADC) in the brain of rats chronically exposed to lead acetate
  168. Brain Region-Selective Mechanisms Contribute to the Progression of Cerebral Alterations in Acute Liver Failure in Rats
  169. Haemodynamic effects of long-term administration of sildenafil in normotensive pregnant and non-pregnant rats
  170. Differential long-term effects of developmental exposure to polychlorinated biphenyls 52, 138 or 180 on motor activity and neurotransmission. Gender dependence and mechanisms involved
  171. Treatment with sildenafil prevents impairment of learning in rats born to pre-eclamptic mothers
  172. Hyperammonemia Induces Neuroinflammation That Contributes to Cognitive Impairment in Rats With Hepatic Encephalopathy
  173. Developmental exposure to polychlorinated biphenyls 52, 138 or 180 affects differentially learning or motor coordination in adult rats. mechanisms involved
  174. Cyclic GMP pathways in hepatic encephalopathy. Neurological and therapeutic implications
  175. cGMP modulates stem cells differentiation to neurons in brain in vivo
  176. Effects of developmental exposure to different NDL–PCB congeners on cognitive and motor function. Possible underlying mechanisms. NDL–PCBs session
  177. Motor alterations induced by chronic lead exposure
  178. Neuroinflammation contributes to hypokinesia in rats with hepatic encephalopathy: Ibuprofen restores its motor activity
  179. Hyperammonemia Increases GABAergic Tone in the Cerebellum but Decreases It in the Rat Cortex
  180. Role of NMDA receptors in acute liver failure and ammonia toxicity: Therapeutical implications
  181. Mechanisms of cognitive alterations in hyperammonemia and hepatic encephalopathy: Therapeutical implications
  182. Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy
  183. Acute liver failure-induced death of rats is delayed or prevented by blocking NMDA receptors in brain
  184. Chronic hyperammonemia reduces the activity of neuronal nitric oxide synthase in cerebellum by altering its localization and increasing its phosphorylation by calcium‐calmodulin kinase II
  185. Developmental exposure to polychlorinated biphenyls or methylmercury, but not to its combination, impairs the glutamate–nitric oxide–cyclic GMP pathway and learning in 3-month-old rats
  186. Brain cholinergic impairment in liver failure
  187. Developmental exposure to polychlorinated biphenyls PCB153 or PCB126 impairs learning ability in young but not in adult rats
  188. Magnetic resonance analysis of the effects of acute ammonia intoxication on rat brain. Role of NMDA receptors
  189. NMDA receptors in hyperammonemia and hepatic encephalopathy
  190. Hyperammonaemia alters the mechanisms by which metabotropic glutamate receptors in nucleus accumbens modulate motor function
  191. Motor activity is modulated via different neuronal circuits in rats with chronic liver failure than in normal rats
  192. The function of the glutamate–nitric oxide–cGMP pathway in brain in vivo and learning ability decrease in parallel in mature compared with young rats
  193. Inflammation and hepatic encephalopathy: Ibuprofen restores learning ability in rats with portacaval shunts
  194. Intermittent ethanol exposure induces inflammatory brain damage and causes long‐term behavioural alterations in adolescent rats
  195. Hypolocomotion in rats with chronic liver failure is due to increased glutamate and activation of metabotropic glutamate receptors in substantia nigra
  196. Sensitization to caffeine and cross-sensitization to amphetamine: Influence of individual response to caffeine
  197. Mechanisms of developmental neurotoxicity: Molecular and behavioral correlates
  198. Brain edema and inflammatory activation in bile duct ligated rats with diet‐induced hyperammonemia
  199. Role of extracellular cGMP and of hyperammonemia in the impairment of learning in rats with chronic hepatic failure
  200. Altered Modulation of Motor Activity by Group I Metabotropic Glutamate Receptors in the Nucleus Accumbens in Hyperammonemic Rats
  201. Subchronic intermittent caffeine administration to unilaterally 6-hydroxydopamine-lesioned rats sensitizes turning behaviour in response to dopamine D1 but not D2 receptor agonists
  202. Modulation of NMDA receptors in the cerebellum. II. Signaling pathways and physiological modulators regulating NMDA receptor function
  203. Modulation of NMDA receptors in the cerebellum. 1. Properties of the NMDA receptor that modulate its function
  204. Caffeine and the dopaminergic system
  205. Sequential activation of soluble guanylate cyclase, protein kinase G and cGMP-degrading phosphodiesterase is necessary for proper induction of long-term potentiation in CA1 of hippocampus
  206. Synthesis of new 2-arylamino-6-trifluoromethylpyridine-3-carboxylic acid derivatives and investigation of their analgesic activity
  207. Chronic hyperammonemia alters motor and neurochemical responses to activation of group i metabotropic glutamate receptors in the nucleus accumbens in rats in vivo
  208. Memantine presents different effects from MK-801 in motivational and physical signs of morphine withdrawal
  209. Subchronic Caffeine Exposure Induces Sensitization to Caffeine and Cross-Sensitization to Amphetamine Ipsilateral Turning Behavior Independent from Dopamine Release
  210. Synthesis of ibuprofen heterocyclic amides and investigation of their analgesic and toxicological properties
  211. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D 1 and D 2 receptor agonists
  212. Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic‐intermittent L‐dopa and A2A receptor blockade plus L‐Dopa in dopamine‐denervated rats
  213. Cross-sensitization between the motor activating effects of bromocriptine and caffeine: role of adenosine A2A receptors